Avyxa Drug Patent Portfolio
Avyxa owns 3 orange book drugs protected by 4 US patents Given below is the list of Avyxa's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12427104 | 01 Apr, 2045 | Active | |
| US10398785 | Pharmaceutical compositions containing taxane-cyclodextrin complexes, method of making and methods of use | 14 Mar, 2036 | Active |
| US11382923 | Stable liquid formulations of cyclophosphamide and processes to prepare the same | 01 Dec, 2035 | Active |
| US10849916 | Stable liquid formulations of cyclophosphamide and its impurities | 13 Jul, 2035 | Active |
Latest Legal Activities on Avyxa's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Avyxa.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Application Is Considered Ready for Issue | 08 Sep, 2025 | US12427104 |
| Dispatch to FDC | 08 Sep, 2025 | US12427104 |
| Email Notification | 05 Sep, 2025 | US12427104 |
| Mail Response to 312 Amendment (PTO-271) | 05 Sep, 2025 | US12427104 |
| Response to Amendment under Rule 312 | 02 Sep, 2025 | US12427104 |
| Pubs Case Remand to TC | 29 Aug, 2025 | US12427104 |
| Issue Fee Payment Received | 28 Aug, 2025 | US12427104 |
| Issue Fee Payment Verified | 28 Aug, 2025 | US12427104 |
| Amendment after Notice of Allowance (Rule 312) | 28 Aug, 2025 | US12427104 |
| Mail Notice of Allowance | 15 Aug, 2025 | US12427104 |
| Notice of Allowance Data Verification Completed | 12 Aug, 2025 | US12427104 |
| track 1 ON | 29 Jul, 2025 | US12427104 |
| Date Forwarded to Examiner | 29 Jul, 2025 | US12427104 |
| Email Notification | 21 Jul, 2025 | US12427104 |
| Mail Examiner Interview Summary (PTOL - 413) | 21 Jul, 2025 | US12427104 |
Avyxa's Family Patents
Avyxa Drug List
Given below is the complete list of Avyxa's drugs and the patents protecting them.
1. Docivyx
Docivyx is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10398785 | Pharmaceutical compositions containing taxane-cyclodextrin complexes, method of making and methods of use |
14 Mar, 2036
(10 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Docivyx's drug page
2. Frindovyx
Frindovyx is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11382923 | Stable liquid formulations of cyclophosphamide and processes to prepare the same |
01 Dec, 2035
(9 years from now)
| Active |
| US10849916 | Stable liquid formulations of cyclophosphamide and its impurities |
13 Jul, 2035
(9 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Frindovyx's drug page
3. Kyxata
Kyxata is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12427104 |
01 Apr, 2045
(19 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Kyxata's drug page